Cresset Asset Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.53M Buy
21,864
+4,126
+23% +$288K 0.01% 637
2025
Q1
$1.3M Sell
17,738
-1,674
-9% -$123K 0.01% 670
2024
Q4
$1.27M Sell
19,412
-83,234
-81% -$5.45M 0.01% 688
2024
Q3
$8M Buy
102,646
+7,068
+7% +$551K 0.03% 354
2024
Q2
$7.45M Buy
95,578
+40,565
+74% +$3.16M 0.03% 339
2024
Q1
$3.73M Buy
55,013
+6,159
+13% +$417K 0.02% 425
2023
Q4
$3.29M Sell
48,854
-5,409
-10% -$364K 0.02% 410
2023
Q3
$3.67M Buy
54,263
+6,294
+13% +$426K 0.01% 371
2023
Q2
$3.43M Buy
47,969
+42,304
+747% +$3.03M ﹤0.01% 379
2023
Q1
$393K Buy
5,665
+46
+0.8% +$3.19K 0.01% 549
2022
Q4
$282K Sell
5,619
-4,589
-45% -$230K ﹤0.01% 542
2022
Q3
$560K Sell
10,208
-287
-3% -$15.7K 0.01% 476
2022
Q2
$683K Sell
10,495
-3,290
-24% -$214K 0.01% 466
2022
Q1
$913K Sell
13,785
-7,934
-37% -$525K 0.01% 432
2021
Q4
$1.27M Sell
21,719
-5,897
-21% -$343K 0.01% 387
2021
Q3
$1.66M Buy
27,616
+15,315
+125% +$920K 0.02% 262
2021
Q2
$737K Buy
12,301
+278
+2% +$16.7K 0.01% 441
2021
Q1
$598K Buy
12,023
+5,755
+92% +$286K 0.01% 430
2020
Q4
$313K Sell
6,268
-739
-11% -$36.9K 0.01% 542
2020
Q3
$384K Buy
7,007
+561
+9% +$30.7K 0.01% 432
2020
Q2
$341K Sell
6,446
-330
-5% -$17.5K 0.01% 424
2020
Q1
$303K Buy
6,776
+880
+15% +$39.4K 0.01% 386
2019
Q4
$294K Sell
5,896
-2,269
-28% -$113K 0.01% 436
2019
Q3
$364K Buy
+8,165
New +$364K 0.01% 327
2019
Q2
Sell
-6,638
Closed -$268K 586
2019
Q1
$268K Buy
6,638
+3,016
+83% +$122K 0.01% 294
2018
Q4
$138K Buy
+3,622
New +$138K 0.01% 266